A detailed history of Farther Finance Advisors, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 7,606 shares of CDNA stock, worth $162,920. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,606
Previous 7,606 -0.0%
Holding current value
$162,920
Previous $117 Million 103.02%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$7.56 - $16.15 $1,134 - $2,422
150 Added 2.01%
7,606 $117 Million
Q1 2024

May 13, 2024

SELL
$7.96 - $12.37 $23 - $37
-3 Reduced 0.04%
7,456 $76.9 Million
Q4 2023

Feb 14, 2024

BUY
$4.9 - $12.86 $700 - $1,838
143 Added 1.95%
7,459 $89.5 Million
Q3 2023

Nov 13, 2023

BUY
$7.0 - $11.26 $51,212 - $82,378
7,316 New
7,316 $51.2 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.